ISRAEL’S MEDICAL ACHIEVEMENTS
Positive results for “wonder” cancer treatment. I reported previously (Dec 2013) that VB-111 from Israel’s Vascular Biogenics (VBL Therapeutics) had been fast-tracked by the US FDA for the treatment of GBM – aggressive brain cancer. Meanwhile, VBL has announced that VB-111’s Phase 2 trial for thyroid cancer was successful. http://seekingalpha.com/pr/16747478-vbl-therapeutics-reports-full-data-vbminus-111-monotherapy-phase-2-trial-recurrent-thyroid
Co-operating to study cancer. Researchers from Israeli and Palestinian Arab hospitals together found risk factors for B Cell Non-Hodgkin Lymphoma. Studying 823 patients with the disease from both communities, plus a similar number of healthy controls, they found genetic, environmental, lifestyle and medical links.
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0171709
Life-saving prize. Israel’s national volunteer emergency medical services organization, United Hatzalah, received the Jerusalem Prize for excellence in lifesaving. It was awarded in honor of the 3,200 volunteer Emergency Medical Technicians (EMTs), paramedics, and doctors, who work with the organization.
http://www.jems.com/articles/news/2017/02/united-hatzalah-receives-jerusalem-prize-for-excellence-in-life-saving.html
Bacteria sleep to evade antibiotics. Biophysicists from the Hebrew University of Jerusalem have found that bacteria go dormant to prevent being killed by antibiotics. This process also helps the bacteria develop faster resistance and suggests that resistance can be prevented by targeting dormant bacteria with separate treatments.
http://new.huji.ac.il/en/article/33464
Teva’s “blockbuster” treatment pipeline. Israel’s Teva expects FDA approval in 2017 for seven innovative treatments. They include for chronic migraine, multiple sclerosis, Huntington’s Disease and tardive dyskinesia (movement disorder). http://www.globes.co.il/en/article-tevas-pipeline-shows-promise-1001177680
Detecting vertebral fractures. (TY Atid-EDI) Yet another diagnostic algorithm from Israel’s Zebra Medical Vision. This time its machine and deep learning Imaging Analytics engine will be able to detect compression fractures from uploaded scans and also identify people at risk of subsequent osteoporotic fractures.
http://www.fiercebiotech.com/medical-devices/zebra-medical-s-latest-algorithm-detects-vertebral-compression-fractures https://www.zebra-med.com/algorithms/bone-health/
Discovery can help diagnose dyslexics. (TY Avivit) Hebrew University of Jerusalem scientists have discovered that dyslexics have a shorter implicit memory than non-dyslexics. On hearing a sound repeated sometime later, dyslexics failed to recognize it. The findings pave the way to early diagnosis and intervention.
http://new.huji.ac.il/en/article/33409 https://elifesciences.org/content/6/e20557
Brain surgery cures patient of rare tinnitus. For the first time in Israel, doctors at Beersheba’s Soroka-University Medical Center performed a brain catheterization on a patient suffering from severe tinnitus (ringing in the ears). The condition was due to an aneurysm of veins in the brain, causing blood flow to press on air cells in the ear. http://www.jpost.com/Business-and-Innovation/Health-and-Science/Brain-catheterization-treats-rare-tinnitus-482345
16 Palestinian Arab children can hear for the first time. Dr. Michal Kaufmann of Jerusalem’s Hadassah Ein Kerem Hospital performed cochlear implant surgery on 16 Palestinian Arab deaf and dumb children to allow them to hear for the first time in their lives. He performed six of the operations in just one month.
http://www.ynetnews.com/articles/0,7340,L-4924163,00.html
European approval for pain monitor. (TY Atid-EDI) I reported previously (May 2015) on the pain measurement device developed by Israel’s Medasense Biometrics. The innovative PMD200 has now received CE approval, allowing physicians to assess and manage pain for patients who cannot communicate.
http://www.medasense.com/medasense-launches-new-pain-monitoring-device-pmd200-following-european-ce-approval/